Exendin-4 suppressed Aβ-induced [Ca2+]i elevation through L-VDCC and NMDA receptor.
Exendin-4 antagonized decline of p-CaMKIIα induced by Aβ1-42.
Exendin-4 is likely to regulate calcium homeostasis to perform neuroprotection.
The study provides a support for Exendin-4 being used to treat and prevent AD.
The LTP was investigated with homemade stimulation/recording/drug delivery system.